Move log
Jump to navigation
Jump to search
Below is a list of all page moves.
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)- 17:13, 1 March 2019 Warner-admin talk contribs moved page Category:Adult T-cell leukemia-lymphoma medications to Category:Adult T-cell leukemia/lymphoma medications without leaving a redirect
- 17:12, 1 March 2019 Warner-admin talk contribs moved page Adult T-cell leukemia-lymphoma to Adult T-cell leukemia/lymphoma (NCIT conformance)
- 17:11, 1 March 2019 Warner-admin talk contribs moved page Adult T-cell leukaemia-lymphoma to Adult T-cell leukaemia/lymphoma without leaving a redirect
- 16:45, 1 March 2019 Warner-admin talk contribs moved page Category:Wilms' tumor regimens to Category:Wilms tumor regimens without leaving a redirect
- 16:45, 1 March 2019 Warner-admin talk contribs moved page Category:Wilms' tumor medications to Category:Wilms tumor medications without leaving a redirect
- 16:42, 1 March 2019 Warner-admin talk contribs moved page Wilms' tumor to Wilms tumor (NCIT conformance)
- 16:33, 1 March 2019 Warner-admin talk contribs moved page Category:Ewing's sarcoma regimens to Category:Ewing sarcoma regimens without leaving a redirect
- 16:33, 1 March 2019 Warner-admin talk contribs moved page Category:Ewing's sarcoma medications to Category:Ewing sarcoma medications without leaving a redirect
- 16:30, 1 March 2019 Warner-admin talk contribs moved page Ewing's sarcoma to Ewing sarcoma (Consistent with NCIT terminology)
- 21:25, 28 February 2019 Warner-admin talk contribs moved page Chronic lymphocytic leukemia (CLL/SLL) - historical to Chronic lymphocytic leukemia - historical without leaving a redirect
- 19:46, 27 February 2019 Warner-admin talk contribs moved page Category:Venous thromboembolism (VTE) regimens to Category:Venous thromboembolism regimens without leaving a redirect
- 19:44, 27 February 2019 Warner-admin talk contribs moved page Category:Venous thromboembolism (VTE) medications to Category:Venous thromboembolism medications without leaving a redirect
- 19:38, 27 February 2019 Warner-admin talk contribs moved page Category:Heparin-induced thrombocytopenia (HIT) regimens to Category:Heparin-induced thrombocytopenia regimens without leaving a redirect
- 19:37, 27 February 2019 Warner-admin talk contribs moved page Category:Graft versus host disease (GVHD) regimens to Category:Graft versus host disease regimens without leaving a redirect
- 19:36, 27 February 2019 Warner-admin talk contribs moved page Category:Graft versus host disease (GVHD) medications to Category:Graft versus host disease medications without leaving a redirect
- 19:33, 27 February 2019 Warner-admin talk contribs moved page Category:Autoimmune hemolytic anemia (AIHA) regimens to Category:Autoimmune hemolytic anemia regimens without leaving a redirect
- 19:29, 27 February 2019 Warner-admin talk contribs moved page Category:Paroxysmal nocturnal hemoglobinuria (PNH) regimens to Category:Paroxysmal nocturnal hemoglobinuria regimens without leaving a redirect
- 19:29, 27 February 2019 Warner-admin talk contribs moved page Category:Paroxysmal nocturnal hemoglobinuria (PNH) medications to Category:Paroxysmal nocturnal hemoglobinuria medications without leaving a redirect
- 19:22, 27 February 2019 Warner-admin talk contribs moved page Category:Atypical hemolytic-uremic syndrome (aHUS) regimens to Category:Atypical hemolytic-uremic syndrome regimens without leaving a redirect
- 19:22, 27 February 2019 Warner-admin talk contribs moved page Category:Atypical hemolytic-uremic syndrome (aHUS) medications to Category:Atypical hemolytic-uremic syndrome medications without leaving a redirect
- 19:19, 27 February 2019 Warner-admin talk contribs moved page Category:Chronic lymphocytic leukemia (CLL/SLL) regimens to Category:Chronic lymphocytic leukemia regimens without leaving a redirect
- 19:19, 27 February 2019 Warner-admin talk contribs moved page Category:Immune thrombocytopenia (ITP) regimens to Category:Immune thrombocytopenia regimens without leaving a redirect
- 19:18, 27 February 2019 Warner-admin talk contribs moved page Category:Chronic lymphocytic leukemia (CLL/SLL) medications to Category:Chronic lymphocytic leukemia medications without leaving a redirect
- 19:15, 27 February 2019 Warner-admin talk contribs moved page Category:Immune thrombocytopenia (ITP) medications to Category:Immune thrombocytopenia medications without leaving a redirect
- 18:26, 27 February 2019 Warner-admin talk contribs moved page Paroxysmal nocturnal hemoglobinuria (PNH) to Paroxysmal nocturnal hemoglobinuria
- 18:25, 27 February 2019 Warner-admin talk contribs moved page Autoimmune hemolytic anemia (AIHA) to Autoimmune hemolytic anemia
- 18:25, 27 February 2019 Warner-admin talk contribs moved page Atypical hemolytic-uremic syndrome (aHUS) to Atypical hemolytic-uremic syndrome
- 18:23, 27 February 2019 Warner-admin talk contribs moved page Immune thrombocytopenia (ITP) to Immune thrombocytopenia
- 18:21, 27 February 2019 Warner-admin talk contribs moved page Venous thromboembolism (VTE) to Venous thromboembolism
- 18:20, 27 February 2019 Warner-admin talk contribs moved page Heparin-induced thrombocytopenia (HIT) to Heparin-induced thrombocytopenia
- 18:17, 27 February 2019 Warner-admin talk contribs moved page Graft versus host disease (GVHD) to Graft versus host disease
- 18:07, 27 February 2019 Warner-admin talk contribs moved page Chronic lymphocytic leukemia (CLL/SLL) to Chronic lymphocytic leukemia
- 20:20, 7 February 2019 Jwarner talk contribs moved page Heparin to Unfractionated heparin (UFH) (Concept refinement)
- 19:17, 6 February 2019 Jwarner talk contribs moved page Caplacizumab (ALX-0081) to Caplacizumab (Cablivi) (FDA approval)
- 20:29, 4 February 2019 Warner-admin talk contribs moved page Category:Radioimmunotherapy to Category:Radioimmunotherapeutic without leaving a redirect (Concept refinement)
- 17:37, 3 February 2019 Warner-admin talk contribs moved page Category:Discontinued to Category:Discontinued drugs without leaving a redirect (Concept refinement)
- 17:36, 3 February 2019 Warner-admin talk contribs moved page Category:Halted to Category:Halted drugs without leaving a redirect (Concept refinement)
- 17:35, 3 February 2019 Warner-admin talk contribs moved page Category:Investigational to Category:Investigational drugs without leaving a redirect (Concept refinement)
- 17:28, 3 February 2019 Warner-admin talk contribs moved page Category:Immunotherapy to Category:Immunotherapeutic without leaving a redirect (Disambiguate from the regimen type = immunotherapy)
- 17:28, 3 February 2019 Warner-admin talk contribs moved page Category:Endocrine therapy to Category:Endocrine therapeutic without leaving a redirect (Disambiguate from the regimen type = endocrine therapy)
- 17:28, 3 February 2019 Warner-admin talk contribs moved page Category:Chemotherapy to Category:Chemotherapeutic without leaving a redirect (Disambiguate from the regimen type = chemotherapy)
- 15:47, 28 January 2019 Warner-admin talk contribs moved page Lomustine (Ceenu) to Lomustine (CCNU) (Better known by another generic name)
- 15:45, 28 January 2019 Warner-admin talk contribs moved page Carmustine (BiCNU) to Carmustine (BCNU) (Better known by another generic name)
- 15:44, 28 January 2019 Warner-admin talk contribs moved page Mercaptopurine (Purinethol) to Mercaptopurine (6-MP) (Better known by another generic name)
- 15:44, 28 January 2019 Warner-admin talk contribs moved page Cytarabine (Cytosar) to Cytarabine (Ara-C) (Better known by another generic name)
- 19:05, 18 December 2018 Jwarner talk contribs moved page SL-401 to Tagraxofusp (Elzonris) (Generic name available)
- 19:02, 18 December 2018 Jwarner talk contribs moved page SGN-CD19A to Denintuzumab mafodotin (SGN-CD19A) (Generic name available)
- 18:57, 18 December 2018 Jwarner talk contribs moved page CC-292 (AVL-292) to Spebrutinib (CC-292) (Generic name available)
- 18:49, 29 November 2018 Jwarner talk contribs moved page Gilteritinib (ASP2215) to Gilteritinib (Xospata) (FDA approval)
- 03:20, 27 November 2018 Jwarner talk contribs moved page Larotrectinib (LOXO-101) to Larotrectinib (Vitrakvi) (FDA approval)